Proceso atención de enfermería en paciente adulto con tuberculosis Multidrogorresistente – MDR.
| dc.contributor.advisor | Moncayo Fuentes, Juliana Jenny | |
| dc.contributor.author | Brunis Ramírez, Elvis Javier | |
| dc.date.accessioned | 2025-05-16T17:01:28Z | |
| dc.date.available | 2025-05-16T17:01:28Z | |
| dc.date.issued | 2025 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/18364 | |
| dc.description | This clinical case study focuses on a 63-year-old male patient who presented with a clinical picture lasting more than 15 days, characterized by intermittent cough with whitish mucous expectoration and general discomfort. The patient was diagnosed with pulmonary tuberculosis (TB) through a BK test on January 25, 2024 (+). He initially started first-line anti-TB treatment on January 25, 2024, which continued until February 2, 2024 (7 doses). However, molecular test results obtained on February 2, 2024, revealed GENEXPERT Ultra MTB detected with resistance to rifampicin and GENEXPERT XDR with resistance to isoniazid. Consequently, the case was presented to the MDR-TB treatment committee for further evaluation. A head-to-toe assessment was conducted, along with complementary diagnostic methods, confirming the presence of multidrug-resistant pulmonary tuberculosis (MDR-TB). Additionally, Marjory Gordon’s altered functional health patterns were identified, highlighting the patient’s health compromise. These alterations were promptly addressed by the nursing staff through the Nursing Care Process (PAE), utilizing NANDA, NOC, and NIC taxonomies. The patient is currently receiving anti-TB treatment as per the committee’s recommendations. | es_ES |
| dc.description | This clinical case study focuses on a 63-year-old male patient who presented with a clinical picture lasting more than 15 days, characterized by intermittent cough with whitish mucous expectoration and general discomfort. The patient was diagnosed with pulmonary tuberculosis (TB) through a BK test on January 25, 2024 (+). He initially started first-line anti-TB treatment on January 25, 2024, which continued until February 2, 2024 (7 doses). However, molecular test results obtained on February 2, 2024, revealed GENEXPERT Ultra MTB detected with resistance to rifampicin and GENEXPERT XDR with resistance to isoniazid. Consequently, the case was presented to the MDR-TB treatment committee for further evaluation. A head-to-toe assessment was conducted, along with complementary diagnostic methods, confirming the presence of multidrug-resistant pulmonary tuberculosis (MDR-TB). Additionally, Marjory Gordon’s altered functional health patterns were identified, highlighting the patient’s health compromise. These alterations were promptly addressed by the nursing staff through the Nursing Care Process (PAE), utilizing NANDA, NOC, and NIC taxonomies. The patient is currently receiving anti-TB treatment as per the committee’s recommendations. | es_ES |
| dc.description.abstract | El presente estudio de caso clínico está aplicado en paciente de sexo masculino de 63 años de edad, por presentar cuadro clínico de más de 15 días con tos esporádica mas expectoración mucosa blanquecina, malestar general diagnosticado con o con tb pulmonar por bk 25/01/24 (+). Luego de realizar tratamiento antifimico. Inicia tratamiento antifimico esquema uno el 25/01/2024 hasta el 2/02/24 (7 dosis) en que se obtiene los resultados de pruebas moleculares el 2/02/2024 GENEXPERT ultra mtb detectado resistente a Rifampicina y GENEXPERT XDR resistente a isoniazida. Por lo que se presenta caso al comité para dictamen de tratamiento MDR. Se realizó valoración cefalocaudal más métodos de diagnostico complementarios donde se comprueba la existencia de Tuberculosis pulmonar multidrogo resistente MDR y se identificaron los patrones funcionales alterados de Marjory Gordon que estaban comprometiendo la salud del paciente. Los cuales fueron tratados de inmediato por el personal de enfermería por medio del Proceso Atención de Enfermería y sus taxonomías NANDA, NOC Y NIC. Paciente recibe tratamiento antifímico según criterio de comité. | es_ES |
| dc.format.extent | 51 p. | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | Babahoyo: UTB-FCS, 2025 | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| dc.subject | Tuberculosis Multirresistente | es_ES |
| dc.subject | Agentes antituberculosos | es_ES |
| dc.subject | Resistencia bacteriana | es_ES |
| dc.subject | Tuberculosis latente | es_ES |
| dc.subject | Sensibilidad a antifímicos | es_ES |
| dc.subject.other | Enfermería | es_ES |
| dc.title | Proceso atención de enfermería en paciente adulto con tuberculosis Multidrogorresistente – MDR. | es_ES |
| dc.type | bachelorThesis | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States